Gemzell-Danielsson K

No ORCID on file · 34 papers in corpus
other 2026
NPJ breast cancer ·doi:10.1038/s41523-026-00998-x

Women with germline BRCA1 pathogenic variants face a very high risk of early-onset triple-negative breast cancer (TNBC), with risk-reducing mastectomy currently the only established preventive option. Emerging evidence suggests aberrant pro…

observational 2026
International journal of cancer ·doi:10.1002/ijc.70354

The DNA methylation-based WID-qEC test, applied to cervico-vaginal samples, has been validated for the accurate detection of endometrial and cervical cancers. However, a small proportion of women test positive despite the absence of these c…

lab-animal 2025
·doi:10.20944/preprints202501.0736.v1

Background/Objectives: Endometriosis has a marked impact on fertility, although the mechanisms behind this relationship remain poorly understood, particularly in cases without significant anatomical distortions or in the context of ovarian …

other 2025
medRxiv : the preprint server for health sciences ·doi:10.1101/2025.10.22.25338556

Endometriosis is a common chronic gynecological disorder with complex and poorly understood etiology and no definitive cure. Beyond pain and infertility, affected individuals frequently experience psychiatric comorbidities, often attributed…

2024
·doi:10.1101/2024.02.27.580606

Abstract Current therapeutics of endometriosis are limited to hormonal action on endometriotic lesions to disrupt their growth. Based on the recent findings of the high utilization of glycolysis over oxidative metabolism (Warburg-like effec…

lab-animal 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1465393

BACKGROUND: Endometriosis is characterized by the ectopic growth of endometrial-like cells, causing chronic pelvic pain, adhesions and impaired fertility in women of reproductive age. Usually, these lesions grow in the peritoneal cavity in …

other 2024
BMJ open ·doi:10.1136/bmjopen-2024-090402

BACKGROUND: Mifepristone is a selective progesterone receptor modulator with decades of data demonstrating its potential as a highly effective emergency as well as non-emergency contraceptive. Despite considerable evidence pointing to the p…

other 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1026168

OBJECTIVE: Bromocriptine treatment has been shown to reduce menstrual bleeding and pain in women with adenomyosis in a pilot clinical trial. The underlying mechanism contributing to the treatment effect is however unknown. The purpose of th…

diagnostic-accuracy 2023
·doi:10.20944/preprints202306.0024.v1

Our aim was to compare the inter-rater agreement of Transvaginal ultrasonography (TVS) with Magnetic Resonance Imaging (MRI) regarding diagnosing adenomyosis and for various predefined imaging features of adenomyosis in the same set of wome…

review 2023
Breast cancer research : BCR ·doi:10.1186/s13058-023-01661-0

Many factors, including reproductive hormones, have been linked to a woman's risk of developing breast cancer (BC). We reviewed the literature regarding the relationship between ovulatory menstrual cycles (MCs) and BC risk. Physiological va…

rct 2022
Genome medicine ·doi:10.1186/s13073-022-01063-5

BACKGROUND: Breast cancer is a leading cause of death in premenopausal women. Progesterone drives expansion of luminal progenitor cells, leading to the development of poor-prognostic breast cancers. However, it is not known if antagonising …

observational 2022
The Lancet regional health. Europe ·doi:10.1016/j.lanepe.2022.100470

BACKGROUND: Evidence on a possible association between newer hormonal contraceptives (HC) and risk of breast cancer remains inconclusive, especially as concerns progestogen-only methods. METHODS: In this nationwide prospective cohort study…

other 2022
BMJ open ·doi:10.1136/bmjopen-2021-052192

INTRODUCTION: Medical treatment is a less invasive alternative to surgical management of missed miscarriage. Studies have shown that pretreatment with mifepristone can increase the complete abortion rate in management of first-trimester mis…

review 2021
Advances in therapy ·doi:10.1007/s12325-020-01564-y

INTRODUCTION: Up to one-third of women of reproductive age experience heavy menstrual bleeding (HMB). HMB can give rise to iron deficiency (ID) and, in severe cases, iron-deficiency anemia (IDA). AIM: To review current guidelines for the m…

guideline 2021
Contraception ·doi:10.1016/j.contraception.2021.07.004

OBJECTIVE: To develop a minimum data set, known as a core outcome set, for future abortion randomized controlled trials. STUDY DESIGN: We extracted outcomes from quantitative and qualitative systematic reviews of abortion studies to assess…

lab-animal 2020
Stem cell research & therapy ·doi:10.1186/s13287-019-1496-2

BACKGROUND: In Asherman's syndrome (AS), intrauterine scarring and fibrotic adhesions lead to menstrual disorders, pregnancy loss, or infertility. A few clinical trials have piloted cell therapy to overcome AS. Understanding the role of the…

2020
·doi:10.1101/2020.07.17.203844

Abstract The endometrium undergoes regular regeneration and stromal proliferation as part of the normal menstrual cycle. To better understand cellular interactions driving the mechanisms in endometrial regeneration we employed single-cell R…

lab-animal 2020
Human Reproduction ·doi:10.1093/humrep/deaa164

STUDY QUESTION: What is the physiological role of transforming growth factor-beta (TGF-β1) and syndecans (SDC1, SDC4) in endometriotic cells in women with endometriosis? SUMMARY ANSWER: We observed an abnormal, pro-invasive phenotype in a …

nonrandomized-trial 2020
European journal of obstetrics, gynecology, and reproductive biology ·doi:10.1016/j.ejogrb.2020.08.040

OBJECTIVE: Vaginal bromocriptine significantly reduces heavy menstrual bleeding and pain in women with diffuse adenomyosis. The aim of this pilot study was to evaluate whether imaging findings of adenomyosis, as assessed by transvaginal ult…

meta-analysis 2019
Reproductive BioMedicine Online ·doi:10.1016/j.rbmo.2019.11.003

RESEARCH QUESTION: Women with endometriosis are considered to be at higher risk of several chronic diseases, such as autoimmune disorders, gynaecological cancers, asthma/atopic diseases and cardiovascular and inflammatory bowel diseases. Co…

observational 2019
European journal of epidemiology ·doi:10.1007/s10654-018-0474-9

Some studies have suggested that infertility is a risk factor for endometrial, ovarian and breast cancer. The study aimed to create a comprehensive picture of the association between infertility and the risk of ovarian, endometrial and brea…

other 2018
Human Reproduction ·doi:10.1093/humrep/dey241

STUDY QUESTION: Is there molecular evidence for a link between endometriosis and endometriosis-associated ovarian cancers (EAOC)? STUDY ANSWER: We identified aberrant gene expression signatures associated with malignant transformation in a…

meta-analysis 2017
Scientific reports ·doi:10.1038/s41598-017-10098-3

Previous transcriptome studies of the human endometrium have revealed hundreds of simultaneously up- and down-regulated genes that are involved in endometrial receptivity. However, the overlap between the studies is relatively small, and we…

other 2017
Contraception ·doi:10.1016/j.contraception.2016.12.009
other 2017
Acta obstetricia et gynecologica Scandinavica ·doi:10.1111/aogs.13155

Endometriosis is a common disease with severe impact on quality of life but its etiology is still poorly understood and diagnosis and adequate treatment is frequently delayed. In this theme issue of AOGS we have included reviews and origina…